Shuttle Pharmaceuticals Holdings, Inc. stock analysis
Want to see SHPH full AI Analyst Report?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price & Analysis
SHPH Stock Chart & Stats
- Day’s Range
- $4.16 - $4.92
- 52-Week Range
- $2.58 - $44.39
- Previous Close
- $4.53
- Volume
- N/A
- Average Volume (3M)
- 39.34K
- Market Cap
- $20.20M
- Enterprise Value
- $1.68T
- Total Cash (Recent Filing)
- $90.24K
- Total Debt (Recent Filing)
- $195.16K
- Price to Earnings (P/E)
- ―
- Beta
- 1.77
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strategic Management Restructuring
The appointment of a new interim CEO and CSO aims to enhance business focus and capital market engagement, potentially improving strategic execution and financial management.
Successful Fundraising
The successful fundraising provides critical capital to fund Phase II clinical trials and meet Nasdaq’s equity requirements, supporting operational continuity and growth.
Clinical Trial Progress
Investing in Phase II trials for its lead product candidate indicates progress in product development, which is crucial for future revenue generation and market positioning.
Bears Say
Financial Distress
The lack of revenue and ongoing losses highlight financial instability, posing risks to sustainability and necessitating urgent strategic and operational adjustments.
High Debt Levels
The high-interest revolving loan adds financial strain, increasing debt burden and interest obligations, which could limit operational flexibility and strategic options.
Negative Cash Flow
Persistent negative cash flow reflects unsustainable operations, requiring effective cost management and revenue generation strategies to ensure long-term viability.
Shuttle Pharmaceuticals Holdings, Inc. News
SHPH FAQ
What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christopher Robert Cooper
- Employees
- 2
- Website
- www.shuttlepharma.com
- Address
- 401 Professional Drive, Gaithersburg, MD, 20879, US
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 13 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 1 | 0 | 11 |












